Healthcare industry observers witnessed an unusual executive transition when Bill Mixon departed Advanced Diabetes Supply Group just three months after Cardinal Health completed its $1.1 billion acquisition in April 2025. Rather than remaining with the acquiring company or pursuing another CEO opportunity, Mixon immediately announced his partnership with Reeve Waud’s Chicago-based private equity firm.
This swift pivot from leading an acquired company to becoming an executive partner at Waud Capital Partners reflects evolving dynamics in healthcare services. Successful operators increasingly view private equity partnerships as opportunities to replicate their value creation expertise across multiple platforms rather than limiting themselves to single company optimization.
The Cardinal Health Transaction
Cardinal Health’s strategic rationale for the Advanced Diabetes Supply Group acquisition centered on strengthening its at-Home Solutions business unit, which serves more than 5 million patients annually. The transaction valued ADSG’s specialized capabilities in diabetes supply distribution and patient relationship management.
ADSG’s impressive scale attracted Cardinal Health’s attention: $1 billion in revenue serving nearly 500,000 patients annually through comprehensive diabetes supply and management services. The company’s direct-to-patient delivery model aligned with Cardinal Health’s strategy to expand home-based healthcare services.
Integration into Cardinal Health’s at-Home Solutions division represented a logical combination. Both organizations focus on delivering critical medical supplies directly to patients’ homes, creating opportunities for operational synergies and expanded service offerings across chronic disease management.
Rob Schlissberg, president of Cardinal Health at-Home Solutions, emphasized the strategic fit: “With the addition of ADSG, we are strengthening our core and strategically positioning our business to grow alongside the demand for accessible diabetes care.”
Executive Transition Strategy
Mixon’s departure timing suggests deliberate planning rather than reactive decision-making. Three months post-acquisition provided sufficient time to ensure smooth integration while allowing him to pursue new opportunities before committing to long-term employment with Cardinal Health.
This pattern reflects broader industry trends where successful healthcare executives increasingly partner with private equity firms to build new platforms. The approach allows operators to leverage their expertise across multiple companies rather than optimizing single entities for acquiring corporations.
Waud Capital Partners’ executive-first approach appeals to proven healthcare leaders seeking entrepreneurial opportunities. Rather than joining as hired management post-acquisition, executives like Mixon become partners in the value creation process from the beginning of platform development.
Reeve Waud’s philosophy that “exceptional people drive exceptional value” creates alignment between successful healthcare executives and the firm’s investment strategy. This approach has produced consistent results across Waud Capital’s healthcare portfolio since the firm’s founding in 1993.
Platform Building Opportunity
Healthcare supply chain market fragmentation creates significant consolidation opportunities for experienced operators with access to investment capital. Market dynamics favor companies that combine product distribution with value-added services, particularly in chronic care and population health management segments.
Mixon’s expertise spans multiple healthcare supply chain areas, from his current experience in diabetes supplies to his previous leadership of National Seating & Mobility in complex rehabilitation technology. This operational breadth positions him to evaluate acquisition opportunities across related healthcare service segments.
The partnership targets home distribution services, other value-add specialty distribution, outsourced provider equipment services, and chronic care and population health management solutions. These areas align with Mixon’s proven capabilities while addressing significant market opportunities.
Kyle Lattner and Mike Lehman, recently promoted to Partner and Principal respectively at Waud Capital Partners, will support healthcare investment efforts. Their experience across multiple healthcare segments provides operational insights for platform building initiatives.
The $100+ million equity commitment demonstrates Waud Capital’s conviction in both Mixon’s capabilities and the healthcare supply chain opportunity. This investment size reflects the firm’s ambition to build a market-leading platform through strategic acquisitions and organic growth initiatives.
Mixon expressed enthusiasm for the partnership structure: “Waud Capital’s executive partnership approach, dedicated ecosystem resources, and deep investing experience across relevant areas make the firm a highly attractive partner.”
Since founding the firm as a single-person operation, Reeve Waud has evolved the organization into a $4.6 billion investment platform capable of supporting ambitious healthcare consolidation initiatives. The transition from Cardinal Health acquisition to private equity partnership illustrates Reeve Waud’s continued ability to attract exceptional healthcare executives to Waud Capital Partners.